Dr. Michael Dixon is president and CEO of the UNeMed Corporation, a company that works with faculty, students, and staff of the University of Nebraska Medical Center, the University of Nebraska at Omaha, and Nebraska Medicine to help commercialize innovative, new ideas that have the potential to improve public health for Nebraska residents and beyond. Under his leadership, UNeMed has more than doubled the number of new inventions and licenses it executes each year. In addition, UNeMed revenues have increased 10-fold. In this show, Dixon talks about some of the major innovation breakthroughs that have emerged from UNeMed, including a game-changing malaria therapeutic, and the challenges and pleasures of creating a solid culture and process around big egos, smart people, and investment. Dixon also shares how he found his way from science to this quasi-entrepreneurship role and what he sees for the future.